ALNY
Alnylam Pharmaceuticals Inc
232.70$
+3.6%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.74 | -0.24 | -0.65 | 0.98 | 0.34 | -0.74 | -0.91 | 1.19 | 2.37 | 1.20 | 0.51 | 0.54 | 4.59 | |
| 0.18 | 0.11 | 0.11 | 0.12 | 0.38 | -0.16 | 0.11 | 0.11 | 0.10 | 0.10 | 0.10 | 0.10 | 0.40 | |
| 0.49 | 0.33 | 0.36 | 0.70 | 0.36 | 0.71 | 0.44 | 0.86 | 0.79 | 0.53 | 0.51 | 0.63 | 2.43 | |
| 1.24 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.19 | 0.05 | -0.96 | -0.39 | 0.24 | -0.58 | -1.67 | 0.39 | -1.49 | -0.54 | -2.04 | 0.22 | -3.83 | |
| 0.13 | 0.12 | 0.10 | 0.06 | 0.03 | 0.07 | 0.07 | 0.11 | 0.09 | 0.17 | 0.16 | 0.25 | 0.67 | |
| -0.08 | -1.92 | -0.54 | 0.27 | -0.24 | -0.41 | 0.88 | -1.09 | 3.65 | -0.27 | -0.18 | -2.63 | 0.54 | |
| – | – | – | – | – | – | – | – | – | -0.39 | – | – | – | |
| 0.25 | 0.31 | 0.23 | 1.04 | 0.80 | 0.24 | 0.34 | 0.41 | -3.26 | 0.33 | 0.11 | 0.17 | -2.63 | |
| 2.86 | -1.75 | -1.04 | 2.26 | 1.02 | -1.04 | 0.41 | 0.72 | 2.74 | 1.22 | 0.39 | -1.93 | 2.38 | |
| 2.61 | -0.36 | -0.75 | 0.92 | 0.31 | -0.81 | -0.98 | 1.08 | 2.28 | 1.03 | 0.35 | 0.29 | 3.92 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.